| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Feb 20, 2024 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $15.62 | $40,840 | -2.35% |
| Jan 16, 2024 | Jan 18, 2024 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $14.47 | $35,234 | -2.52% |
| Dec 13, 2023 | Dec 14, 2023 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $15.37 | $42,905 | -2.81% |
| Oct 30, 2023 | Oct 31, 2023 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $12.02 | $28,362 | -2.54% |
| Oct 02, 2023 | Oct 04, 2023 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $12.68 | $37,305 | -3.36% |
| Jun 16, 2023 | Jun 21, 2023 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $14.4 | $23,835 | -1.85% |
| Feb 16, 2023 | Feb 17, 2023 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $15.1 | $14,661 | -1.09% |
| Jan 17, 2023 | Jan 19, 2023 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $21.24 | $51,043 | -3.20% |
| Oct 03, 2022 | Oct 05, 2022 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $18.73 | $48,455 | -3.36% |
| Jun 16, 2022 | Jun 21, 2022 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $10.75 | $19,006 | -2.25% |
| Feb 16, 2022 | Feb 18, 2022 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $9.05 | $8,905 | -1.27% |
| Oct 04, 2021 | Oct 06, 2021 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $33.17 | $88,199 | -5.46% |
| Feb 16, 2021 | Feb 19, 2021 | Sherman Matthew L EVP Chief Medical Officer | Sell | Deciphera Pharmaceuticals, Inc. | DCPH | $48.87 | $6,451 | -0.27% |
| Apr 03, 2018 | Apr 06, 2018 | Sherman Matthew L Dir | Buy | Pulmatrix, Inc. | PULM | ~ | $0 | +50.00% |
| Apr 03, 2018 | Apr 04, 2018 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $38.43 | $176,772 | -5.62% |
| Jan 03, 2018 | Jan 05, 2018 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $42.71 | $197,868 | -5.36% |
| Sep 12, 2017 | Sep 14, 2017 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $38.41 | $706,799 | -17.54% |
| Jul 05, 2017 | Jul 07, 2017 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $32 | $512,000 | -13.23% |
| Jan 04, 2017 | Jan 06, 2017 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $27.46 | $54,916 | -1.87% |
| Jul 01, 2016 | Jul 06, 2016 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $34.74 | $903,143 | -24.05% |
| Apr 06, 2016 | Apr 08, 2016 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $32 | $832,000 | -21.65% |
| Oct 15, 2015 | Oct 16, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $23.28 | $139,669 | -5.65% |
| Sep 16, 2015 | Sep 18, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $33.24 | $66,477 | -1.85% |
| Aug 18, 2015 | Aug 19, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $31.13 | $217,900 | -14.26% |
| Jul 20, 2015 | Jul 21, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $32.46 | $194,735 | -12.12% |
| Jun 18, 2015 | Jun 19, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $31.54 | $220,790 | -13.54% |
| May 18, 2015 | May 19, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $32.37 | $226,576 | -13.18% |
| Apr 20, 2015 | Apr 21, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $33.52 | $167,620 | -9.52% |
| Mar 18, 2015 | Mar 20, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $41.18 | $247,071 | -14.12% |
| Mar 04, 2015 | Mar 06, 2015 | Sherman Matthew L EVP Chief Medical Officer | Sell | Acceleron Pharma Inc | XLRN | $40.75 | $285,222 | -15.66% |